We are pleased to welcome @Lara Zibners, MD as an Advisor to Cern.

Dr. Zibners is Co-Founder and Chairman of Calla Lily Clinical Care and a long-time advocate for innovation in women’s health. As a physician and entrepreneur operating across the U.S. and Europe, she brings a global lens to commercialization strategy and platform growth.

The women’s health medical device ecosystem is collaborative and interconnected. Over the past several years, our leadership teams have shared insights on what it truly takes to build companies from the ground up and bring meaningful technologies to market.

We look forward to working together as Cern advances its light-based, non-hormonal women’s health platform.

More News

20 April 23

Interview Outtake 5: Prevalence & Symptoms

25 November 25

HITLAB x Cern Partnership Announcement

New York, NY – November 5, 2025 — HITLAB, a global leader in digital health innovation and evidence generation, today announced...

20 April 23

Interview Outtake #4: Success and career